APA (7th ed.) Citation

Passweg, J. R., Giagounidis, A., Simcock, M., Aul, C., Dobbelstein, C., Stadler, M., . . . Ganser, A. (2011). Immunosuppressive therapy for patients with myelodysplastic syndrome: A prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care—SAKK 33/99. Journal of clinical oncology, 29(3), . https://doi.org/10.1200/JCO.2010.31.2686

Chicago Style (17th ed.) Citation

Passweg, Jakob R., et al. "Immunosuppressive Therapy for Patients with Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine with Best Supportive Care—SAKK 33/99." Journal of Clinical Oncology 29, no. 3 (2011). https://doi.org/10.1200/JCO.2010.31.2686.

MLA (9th ed.) Citation

Passweg, Jakob R., et al. "Immunosuppressive Therapy for Patients with Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine with Best Supportive Care—SAKK 33/99." Journal of Clinical Oncology, vol. 29, no. 3, 2011, https://doi.org/10.1200/JCO.2010.31.2686.